Streetbeat News

Products Services

HLTH

Cue Health's molecular COVID-19 test has been found to be as accurate as a lab-based PCR test, according to a peer-reviewed independent study published in Microbiology Spectrum. The study found that Cue's test had a 99.4% match with lab-based PCR tests and 100% clinical sensitivity to detect positive cases. Cue Health recently received De Novo authorization from the FDA for its COVID-19 test.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:21 pm

AAPL

According to industry sources, Apple's next-generation MacBook Pro will feature MiniLED backlighting technology. This feature is expected to remain a key part of MacBook Pros until 2026.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:17 pm

BCTX

BriaCell has partnered with New York Cancer & Blood Specialists (NYCBS) for a pivotal Phase 3 study of Bria-IMT in advanced breast cancer.

Portfolio Pulse from Bill Haddad

October 04, 2023 | 1:16 pm

AMD

AMZN

GOOGL

MSFT

NVDA

ORCL

Nvidia Corp is considering a strategic shift in its cloud service operations, potentially leasing exclusive space in data centers, which could put it in direct competition with current clients like Amazon Web Services, Microsoft, Oracle, and Google. Meanwhile, Nvidia's GeForce RTX 3060 has become the most popular choice among gamers, according to a Steam hardware survey.

Portfolio Pulse from Anusuya Lahiri

October 04, 2023 | 1:15 pm

ZETA

Zeta Global, a data-driven marketing technology company, reported that its ZETA LIVE 2023 event achieved over 12,000 global viewers.

Portfolio Pulse from Bill Haddad

October 04, 2023 | 1:13 pm

SNX

TD SYNNEX (NYSE:SNX) will be the exclusive North American distributor for the new suite of business products announced by Meta. The products, integrated with the Metaverse, aim to reshape business operations. The new Meta Quest 3 headset and the Meta for Work product portfolio will be launched globally in October. These products will first be available in the U.S. and Canada, followed by rollouts across Europe.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:12 pm

NRSN

NeuroSense Therapeutics' drug, PrimeC, has shown significant improvement in the survival rate of induced motor neurons in an in vitro study. The study was conducted in collaboration with the University of Southern California's Ichida Stem Cell Lab, using induced pluripotent stem cells (iPSCs) generated from people living with ALS. In a previous independent study, PrimeC outperformed several other ALS drugs in development and two ALS FDA approved drugs.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:12 pm

AMPG

AmpliTech Group, Inc (NASDAQ:AMPG) has announced new partnerships and an increase in bookings within its Satcom components subdivision, Specialty Microwave. The division has booked $1 million in Q2 and Q3 of 2023, expected to convert to revenue mostly in the first half of 2024. This is attributed to securing business from global entertainment companies such as Warner Bros., Disney, Paramount, and CBS Viacom. The bookings are for assemblies crucial for efficient signal transmission and reception across news, TV, and entertainment networks.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:11 pm

CLSD

Clearside Biomedical announced that its partner, Arctic Vision, has completed enrollment in a Phase 3 clinical trial in China for XIPERE, a treatment for Uveitic Macular Edema. This marks a significant advancement of XIPERE in the Asia-Pacific region.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:10 pm

ROKU

Roku, Inc. (NASDAQ:ROKU) has announced new features to enhance its streaming platform, including personalized content discovery, sports streaming, live TV options, music playlists, and smart home controls. The updates will roll out in the coming months, aiming to make Roku the go-to destination for TV streaming. The company also announced the availability of Roku Express 4K with Voice Remote Pro, exclusively on Amazon in the U.S.

Portfolio Pulse from Benzinga Newsdesk

October 04, 2023 | 1:09 pm